Effects of norepinephrine on α-subtype receptors in the feline pulmonary vascular bed

Critical Care Medicine

Volumn 32, Issue 11, 2004, Pages 2300-2303

  Kaye, Alan D ^a   Hoover, Jason M ^b   Baber, Syed R ^c   Ibrahim, Ikhlass N ^a   Fields, Aaron M ^d  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^c TULANE UNIVERSITY   (United States)

^d FLUSHING HOSPITAL MEDICAL CENTER   (United States)

Author keywords

(1)A subtype and (1)B subtype adrenoceptors; Phospholipase C; Protein kinase C; Pulmonary hypertension; Vasopressor

Indexed keywords

5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ADRENERGIC RECEPTOR; CHLOROETHYLCLONIDINE; NORADRENALIN; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTERY PERFUSION; ARTICLE; CAT; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; FEMALE; LUNG BLOOD VESSEL; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; VASOCONSTRICTION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN II; ANIMALS; CATS; CLONIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ANTAGONISM; DRUG EVALUATION, PRECLINICAL; EPHEDRINE; FEMALE; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; MALE; NOREPINEPHRINE; PHENYLEPHRINE; PIPERAZINES; PULMONARY ARTERY; PULMONARY CIRCULATION; RECEPTORS, ADRENERGIC, ALPHA-1; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS;

EID: 8544273731     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000145589.85559.90     Document Type: Article

References (11)

1. Lawson NW, Meyer DJ Jr: Autonomic nervous system: Physiology and pharmacology. In: Clinical Anesthesia. Third Edition. Barash PG, Cullen BF, Stoelting RK (Eds). Philadelphia, Lippincott Williams and Wilkins, 1997, pp 243-310
2. Blaise G, Langleben D, Hubert B: Pulmonary arterial hypertension: Pathophysiology and anesthetic approach. Anesthesiology 2003; 99:1415-1432
3. Fields AM, Kaye AD, Richards TA, et al: Pulmonary vascular responses to ma huang extract. J Altern Complement Med 2003; 9:727-733
4. Shimamoto YH, Shimamoto H, Kwan CY, et al: Differential effects of putative protein kinase C inhibitors on contraction of rat aortic smooth muscle. Am J Physiol 1993; 264 (Heart Circ Physiol 33): H1300-H1306
5. Rasmussen H, Takuwa Y, Park S: Protein kinase C in the regulation of smooth muscle contraction. FASEB J 1987; 1:177-185
6. Meisenberg G, Simmons WH: Intracellular Messengers. Principles of Medical Biochemistry. St. Louis, MO, Mosby, 1998, pp 577-602
7. Kaye AD, Nossaman BD, Ibrahim IN, et al: Influence of protein kinase C inhibitors on vasoconstrictor responses in the pulmonary vascular bed of cat and rat. Am J Physiol 1995; 268 (Lung Cell Mol Physiol 12): L532-L538
8. Chupron JK, Bazan E, Chang KC, et al: Inhibition of phorbol ester-induced contraction by calmodulin antagonists in rat aorta. Am J Physiol 1991; 261 (Cell Physiol 30):C675-C684
9. Kaye AD, Nossaman BD, Ibrahim IN, et al: Influence of PLC and MLCK inhibitors and the role of L-type calcium channels in the cat pulmonary vascular bed. Am J Physiol 1995; 269 (Lung Cell Mol Physiol 13):L507-L513
10. 2, 12-lipoxygenase, and cyclooxygenase inhibitors in the feline pulmonary bed. Am J Physiol 1997; 272 (Lung Cell Mol Physiol 16):L573-L579
11. Oriowo MA, Chandrasekhar B, Kadavil EA: Alpha-1-adrenoceptor subtypes mediating noradrenafine-induced contraction of pulmonary artery from pulmonary hypertensive rats. Eur J Pharmacol 2003; 482:255-263